Combination vs. single drug for Stenotrophomonas infection
Part of Infections, Lungs & breathing clinical trials.
This study compares treating Stenotrophomonas maltophilia (a hospital-acquired bacterial infection) with two drugs together versus one drug alone. The goal is to see which approach works better and is safer for adult hospital patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older)
- You have a confirmed Stenotrophomonas maltophilia infection from a hospital stay
- You were hospitalized for at least 72 hours from when your infection was identified
- Your infection is not mixed with other bacteria
- You received appropriate antibiotics for at least 48 hours after diagnosis
- Your medical team has complete records of your treatment and outcomes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
This study looks at how well antibiotics work for pneumonia caused by a specific bacterium (Stenotrophomonas maltophilia) in patients who are on breathing machines in the intensive care unit (ICU). It will help doctors choose the best treatment.
This study tests two different pairs of strong antibiotics to see which works better at clearing hard-to-treat bacterial infections that don't respond to standard drugs. You would receive one of these two combinations and be monitored for how well it works and any side effects.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
This trial compares using one antibiotic alone versus a combination of two antibiotics to treat bone infections caused by Pseudomonas aeruginosa. The goal is to see which approach works better for treating the infection.
This study looks at two strong antibiotics, polymyxin B and colistin, given through a vein to treat serious infections like pneumonia or blood infections caused by bacteria that are resistant to many other antibiotics. The goal is to see how well they work and how safe they are.
Hear when a new Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.